topical (skin-restricted) ROR_ antagonist

efficacy in psoriasis model / minipig PK

from GSK-805 and met. stability reduction

Sci. Rep., Apr. 28, 2021

Eternity Bioscience, NJ / Shanghai Hengrui, CN

SHR168442

The Eternity Bioscience/Shanghai Hengrui RORĪ³ antagonist, SHR168442, is a skin-restricted, topical compound intended to treat psoriasis. As a master regulator of Th17 immune cells which are significantly involved in allergic diseases,…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: